The Directors of Landsdowne Labs, LLC, are pleased to announce the appointment of Bryan Laulicht to Chief Executive Officer.","Laulicht, a company cofounder, has served as Lansdowne’s Chief Technology Officer since the company’s formation in 2017. He has also co-founded and served in leadership positions at two other companies focused on applying biophysics and bioengineering approaches to fulfilling unmet medical and safety needs. Both of those companies have been acquired for a combined total greater than $500M.","Laulicht, who will assume his new position on July 3, 2023, was instrumental in developing Landsdowne’s technology-- first as a post-doctoral associate in the laboratories of Robert Langer, of MIT, and of Jeffrey Karp, PhD, at Harvard, and, later, at Landsdowne.